CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...
In this Teach Me in 10, Dr. Cody Palumbo, a Senior Application Scientist in Technical Design at TriLink BioTechnologies, discusses why gRNA purity matters and how advanced purification solutions can ...
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...
Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...
CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...
When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A haploinsufficiency, in which children are born with just one functioning copy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback